3rd SIRIC endorsement for Institut Curie
Following a call for applications, launched in April 2022, the Institut Curie's SIRIC program is one of 8 projects to be awarded the SIRIC label in 2022 by the French national cancer institute in partnership with INSERM and the DGOS.
Previous SIRIC labels have played a decisive role in the integration of scientific and clinical activities with a clear impact on patients (more information). For this new SIRIC, we want to amplify this impact.
A program addressing relapse at 3 levels
- Relapse at the cellular level:
intrinsic mechanisms of relapse
coordinated by Céline Vallot and Yves Allory
- Relapse at the tissue level :
extrinsic mechanisms of relapse
coordinated by Hélène Salmon and Manuel Rodrigues
- Relapse at the organism level:
detection and treatment of relapse
coordinated by Elisabetta Marangoni and François-Clément Bidard
Patients will play a central role in the overall process with the implementation of ambitious initiatives carried out by a group dedicated to health democracy, coordinated by Dominique Stoppa-Lyonnet.
Consult the list of centers endorsed as part of the Integrated Cancer Research Site (SIRIC) endorsement campaign